Cargando…

WDR5 is a prognostic biomarker of brain metastasis from non-small cell lung cancer

BACKGROUND: Lung cancer (LC) is the most frequent caner type and causes the most cancer-related death. Brain metastases (BM) are the deadliest complications of lung cancer, and the prognostic biomarkers of BM are urgently needed. MATERIALS AND METHODS: In our study, we established an inception cohor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Zheng, Liang, Nan, Wang, Na, Jia, Yan, Tian, Cui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9557102/ https://www.ncbi.nlm.nih.gov/pubmed/36249032 http://dx.doi.org/10.3389/fonc.2022.1023776

Ejemplares similares

CCKAR is a biomarker for prognosis and asynchronous brain metastasis of non-small cell lung cancer
por: Liang, Nan, et al.
Publicado: (2023)

NFAT as a Biomarker and Therapeutic Target in Non–Small Cell Lung Cancer–Related Brain Metastasis
por: Peng, Lu, et al.
Publicado: (2021)

Predictive and Prognostic Biomarkers for Lung Cancer Bone Metastasis and Their Therapeutic Value
por: Chai, Xupeng, et al.
Publicado: (2021)

CDK7 is a prognostic biomarker for non-small cell lung cancer
por: Kuempers, Christiane, et al.
Publicado: (2022)

Prediction of bone metastasis in non-small cell lung cancer based on machine learning
por: Li, Meng-Pan, et al.
Publicado: (2023)

Connexins in Lung Cancer and Brain Metastasis
por: Luo, Kai-Jun, et al.
Publicado: (2020)

Circulating Tumor DNA as a Prognostic Biomarker in Localized Non-small Cell Lung Cancer
por: Peng, Muyun, et al.
Publicado: (2020)

Genomic profiling and sites of metastasis in non-small cell lung cancer
por: Chan, Kok Hoe, et al.
Publicado: (2023)

Premalignant Changes in the Bronchial Epithelium Are Prognostic Factors of Distant Metastasis in Non-Small Cell Lung Cancer Patients
por: Pankova, Olga V., et al.
Publicado: (2021)

New prognostic system specific for epidermal growth factor receptor-mutated lung cancer brain metastasis
por: Zhu, Li-Hua, et al.
Publicado: (2023)

Methylation-driven gene DLL3 is a potential prognostic biomarker in ocular melanoma correlating with metastasis
por: Yang, Ludi, et al.
Publicado: (2022)

WDR5 Expression Is Prognostic of Breast Cancer Outcome
por: Dai, Xiaofeng, et al.
Publicado: (2015)

The Histone H3 Lysine 4 Presenter WDR5 as an Oncogenic Protein and Novel Epigenetic Target in Cancer
por: Lu, Kebin, et al.
Publicado: (2018)

Intracardiac Metastasis From Non-Small Cell Lung Cancer
por: Verma, Vivek, et al.
Publicado: (2015)

Mechanisms and Future of Non-Small Cell Lung Cancer Metastasis
por: Zhu, Tianhao, et al.
Publicado: (2020)

GPI Is a Prognostic Biomarker and Correlates With Immune Infiltrates in Lung Adenocarcinoma
por: Han, Jiahui, et al.
Publicado: (2021)

Extra Spindle Pole Bodies-Like 1 Serves as a Prognostic Biomarker and Promotes Lung Adenocarcinoma Metastasis
por: Nie, Zhi, et al.
Publicado: (2022)

Response of Pembrolizumab Alone for Non-small Cell Lung Cancer With Brain Metastasis: A Case Report and Literature Review
por: Marvin, Eric A., et al.
Publicado: (2020)

Clinical features and molecular genetics associated with brain metastasis in suspected early-stage non-small cell lung cancer
por: Kim, Kangjoon, et al.
Publicado: (2023)

A Nomogram for Predicting Brain Metastasis in IIIA-N2 Non-Small Cell Lung Cancer After Complete Resection: A Competing Risk Analysis
por: Sun, Shuang, et al.
Publicado: (2021)

Downregulation of lncRNA XR_429159.1 Linked to Brain Metastasis in Patients With Limited-Stage Small-Cell Lung Cancer
por: Li, Ji, et al.
Publicado: (2021)

MXRA8 is an immune-relative prognostic biomarker associated with metastasis and CD8(+) T cell infiltration in colorectal cancer
por: Tan, Lulu, et al.
Publicado: (2023)

LncRNA-AC02278.4 Is a Novel Prognostic Biomarker That Promotes Tumor Growth and Metastasis in Lung Adenocarcinoma
por: Chen, Xin, et al.
Publicado: (2022)

Editorial: Prognostic factors in non-small cell lung cancer
por: Rahouma, Mohamed, et al.
Publicado: (2023)

Use of comprehensive genomic profiling for biomarker discovery for the management of non-small cell lung cancer brain metastases
por: Abdulhaleem, Mohammed, et al.
Publicado: (2023)

Deleterious AHNAK2 Mutation as a Novel Biomarker for Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer
por: Cui, Yanan, et al.
Publicado: (2022)

Identification and Validation of the Prognostic Stemness Biomarkers in Bladder Cancer Bone Metastasis
por: Kang, Yao, et al.
Publicado: (2021)

Iodine-125 brachytherapy treatment for newly diagnosed brain metastasis in non-small cell lung cancer: A biocentric analysis
por: Yang, Lili, et al.
Publicado: (2022)

Prognostic Value and Related Regulatory Networks of MRPL15 in Non-Small-Cell Lung Cancer
por: Zeng, Yangyang, et al.
Publicado: (2021)

Integrated Analysis of ceRNA Network Reveals Prognostic and Metastasis Associated Biomarkers in Breast Cancer
por: Qian, Da, et al.
Publicado: (2021)

AQP5 Is a Novel Prognostic Biomarker in Pancreatic Adenocarcinoma
por: Chen, Guo, et al.
Publicado: (2022)

Application of Circulating Tumor DNA as a Biomarker for Non-Small Cell Lung Cancer
por: Yang, Jialiang, et al.
Publicado: (2021)

Abscopal Effect after Radiosurgery for Solitary Brain Metastasis from Non-small Cell Lung Cancer
por: Hamilton, Andrew J, et al.
Publicado: (2018)

Circulating Long Noncoding RNAs Act as Diagnostic Biomarkers in Non-Small Cell Lung Cancer
por: Yuan, Shuai, et al.
Publicado: (2020)

Immune cell-lipoprotein imbalance as a marker for early diagnosis of non-small cell lung cancer metastasis
por: Zhang, Wei, et al.
Publicado: (2022)

MECOM/PRDM3 and PRDM16 Serve as Prognostic-Related Biomarkers and Are Correlated With Immune Cell Infiltration in Lung Adenocarcinoma
por: Li, Meng, et al.
Publicado: (2022)

An Externally-Validated Dynamic Nomogram Based on Clinicopathological Characteristics for Evaluating the Risk of Lymph Node Metastasis in Small-Size Non-small Cell Lung Cancer
por: Wu, Yijun, et al.
Publicado: (2020)

Non-Small Cell Lung Carcinoma Biomarker Testing: The Pathologist’s Perspective
por: Brega, Elisa, et al.
Publicado: (2014)

Overexpression of WDR79 in non‐small cell lung cancer is linked to tumour progression
por: Sun, Yang, et al.
Publicado: (2016)

A favourable prognostic marker for EGFR mutant non-small cell lung cancer: immunohistochemical analysis of MUC5B
por: Wakata, Kouki, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_0ungjj5rqb0uh9fm0b60ph1o30